Republic of Moldova vs Qatar: Access to anti-retroviral drugs, male
Republic of Moldova
47.0%
in 2024
Qatar
47.0%
in 2024
Republic of Moldova rank
122nd
Qatar rank
122nd
Access to anti-retroviral drugs, male over time
- Republic of Moldova
- Qatar
How they compare
Republic of Moldova currently reports 47.0% against 47.0% in Qatar, a difference of 0.0%.
The two have swapped places 2 times across 17 shared years of data; in 2000 it was Qatar ahead.
Republic of Moldova ranks 122nd and Qatar ranks 122nd of 141 countries.
Across the 3 decades both report, Republic of Moldova averaged higher in 1 and Qatar in 2.
Head to head by decade
| Decade | Republic of Moldova | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.3% | 0.0% | 0.3% | Republic of Moldova |
| 2010s | 23.0% | 38.4% | 15.4% | Qatar |
| 2020s | 39.2% | 45.2% | 6.0% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Republic of Moldova or Qatar?
- Republic of Moldova, at 47.0% against 47.0% in Qatar as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Republic of Moldova and Qatar?
- 0.0%, with Republic of Moldova ahead.
- How many years of comparable data are there for Republic of Moldova and Qatar?
- 17 years are reported by both, from 2000 to 2024.
- How do Republic of Moldova and Qatar rank globally for access to anti-retroviral drugs, male?
- Republic of Moldova ranks 122nd and Qatar ranks 122nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.